Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03907501 · ClinicalTrials.gov registry record · NA

Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation

A NA study, sponsored by University of California, San Diego.

Terminated
Registry status
NA
Development phase
75
Enrollment target

NCT03907501 is a NA study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03907501, a NA study, was terminated before completion, sponsored by University of California, San Diego.

TERMINATED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

Normal aging can lead to loss of gut microbial biodiversity which is linked to inflammaging and immunosenescence or the loss of immunocompetence. Probiotics, such as VSL#3®, and certain herbal supplements such as Triphala are associated with restoration of gut community architecture, increased gut barrier function and decreased inflammation. The present project will examine the potential benefits of a synbiotic (which denotes a prebiotic plus probiotic, and in this study, is an herbal prebiotic plus probiotic) intervention (8 weeks of supplementation) on gut microbiome profiles assessed via stool, inflammatory blood markers, and questionnaires about gastrointestinal health and mood. In this exploratory study, the investigators will examine psychological and physical functioning at baseline and after 8 weeks of supplementation with synbiotic, Triphala alone, or placebo.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Probiotic
  • DIETARY_SUPPLEMENT Synbiotic

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2019-02-01
Est. Completion 2021-07-12
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT03907501

The ClinicalTrials.gov registry entry for NCT03907501 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT03907501 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03907501 about?

NCT03907501 is a clinical study titled "Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation". Normal aging can lead to loss of gut microbial biodiversity which is linked to inflammaging and immunosenescence or the loss of immunocompetence. Probiotics, such as VSL#3®, and certain herbal supplements such as Triphala are associated with restoration of gut community architecture, increased gut b...

What is the current status of trial NCT03907501?

This trial is currently terminated. It is a NA study. The enrollment target is 75 participants. The study started on 2019-02-01. Estimated completion is 2021-07-12.

What interventions are being tested in trial NCT03907501?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic (DIETARY_SUPPLEMENT), Synbiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03907501?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.